[HTML][HTML] Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for …
AG Pallis, C Gridelli, U Wedding, C Faivre-Finn… - Annals of oncology, 2014 - Elsevier
Non-small-cell lung cancer (NSCLC) is a very common disease in the elderly population
and its incidence in this particular population is expected to increase further, because of the …
and its incidence in this particular population is expected to increase further, because of the …
Hazards of recurrence, second primary, or other tumor at ten years after surgery for non–small-cell lung cancer
N Fink-Neuboeck, J Lindenmann, C Porubsky… - Clinical lung cancer, 2020 - Elsevier
Introduction Better treatment options entail the risk of multiple tumors in a patient's lifetime.
We studied the incidence, risk factors, and prognostic impact of second primaries and other …
We studied the incidence, risk factors, and prognostic impact of second primaries and other …
[HTML][HTML] Preoperative peak oxygen consumption: A predictor of survival in resected lung cancer
J Lindenmann, N Fink-Neuboeck, M Fediuk, A Maier… - Cancers, 2020 - mdpi.com
The peak oxygen consumption (VO2 peak) serves as a prognostic factor in cardio-
respiratory diseases and plays an important role in cancer patients. The long-term …
respiratory diseases and plays an important role in cancer patients. The long-term …
Management of non-small-cell lung cancer in the older adult
A VanderWalde, SK Pal, KL Reckamp - Maturitas, 2011 - Elsevier
The treatment of older adults with non-small cell lung cancer (NSCLC) poses special
challenges for the clinician. Older adults are more likely to have decreased functional …
challenges for the clinician. Older adults are more likely to have decreased functional …
Geriatric oncology
MA Gosney - Age and ageing, 2009 - academic.oup.com
It was only in the early 1980s that Rosemary Yancik who was an epidemiologist in the USA
identified that there were a growing number of older individuals with cancer [1]. Many of the …
identified that there were a growing number of older individuals with cancer [1]. Many of the …
[HTML][HTML] Adjuvant cisplatin and docetaxel for non-small cell lung cancer: the Hospital of the University of Pennsylvania experience
Introduction Cisplatin and docetaxel (Doc) are commonly used for adjuvant therapy for non-
small cell lung cancer based on extrapolation from the metastatic setting. Nevertheless …
small cell lung cancer based on extrapolation from the metastatic setting. Nevertheless …
107 例大细胞肺癌诊治分析
赵峻， 薛奇， 程贵余， 孙克林， 赫捷 - 肿瘤学杂志, 2009 - cqvip.com
[目的] 总结大细胞肺癌的临床特点.[方法] 回顾中国医学科学院肿瘤医院胸外科1961~ 2007
年间收治的107 例大细胞肺癌的临床资料, 对随诊资料完整连续的59 例的生存情况作一统计 …
年间收治的107 例大细胞肺癌的临床资料, 对随诊资料完整连续的59 例的生存情况作一统计 …
[PDF][PDF] Use of a left-sided double-lumen endotracheal tube in a patient with a prior left pneumonectomy
J Lang, M Hartman - AANA journal, 2013 - scholarlyworks.lvhn.org
A 77-year-old man, 7 years after left pneumonectomy, was scheduled for a right upper
pulmonary lobectomy. The early identification of a newly developing carcinoma on the right …
pulmonary lobectomy. The early identification of a newly developing carcinoma on the right …
[PDF][PDF] El tratamiento quirúrgico del cáncer del pulmón en el medio público y privado en la ciudad de Buenos Aires
H Esteva, EB Arribalzaga, CA Cejas… - REVISTA …, 2009 - researchgate.net
Antecedentes: El cáncer del pulmón es una de las principales causas de muerte
oncológica. La cirugía es hoy el único tratamiento que puede ofrecer resultados curativos …
oncológica. La cirugía es hoy el único tratamiento que puede ofrecer resultados curativos …